+ Site Statistics
References:
52,654,530
Abstracts:
29,560,856
PMIDs:
28,072,755
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Multiple drug-susceptibility screening in Mycobacterium bovis: new nucleotide polymorphisms in the embB gene among ethambutol susceptible strains



Multiple drug-susceptibility screening in Mycobacterium bovis: new nucleotide polymorphisms in the embB gene among ethambutol susceptible strains



International Journal of Infectious Diseases 33: 39-44



Pyrazinamide-resistant Mycobacterium bovis isolates of animal origin were assessed for drug susceptibility to five antituberculosis drugs by the agar based Middlebrook 7H11 method as gold standard as well as by a simplified, dichotomous resazurin microtitre assay (d-REMA). A total of 53 M. bovis isolates were typed and tested against isoniazid, rifampin, streptomycin, ethambutol, kanamycin and the control drug pyrazinamide. On the basis of the results obtained, pncA and embB genes were PCR-amplified and DNA-sequenced for all isolates. All M. bovis isolates, classified into 21 spoligotype/MIRU-VNTR profiles, were resistant to pyrazinamide by both methods, as expected. The pncA gene sequencing confirmed the presence of the resistance-conferring H57D mutation. All strains were found to be susceptible to the other five drugs by the agar based gold standard method. The d-REMA was in agreement with these results for all five drugs, with the exception of 12 isolates, which showed ambiguous and therefore inconclusive results in ethambutol testing. Mutations in the embB gene were observed in all 53 isolates: four new single-nucleotide polymorphisms were identified. No association was found between embB genetic profiles and ethambutol resistance results by the gold standard. All M. bovis isolates were sensitive to the most common antituberculosis drugs used for treatment. There was a good agreement between the d-REMA assay and the agar based reference method. Among ethambutol susceptible isolates, four new embB mutations were found.

(PDF emailed within 0-6 h: $19.90)

Accession: 058360949

Download citation: RISBibTeXText

PMID: 25554388

DOI: 10.1016/j.ijid.2014.12.043


Related references

Novel mutations within the embB gene in ethambutol-susceptible clinical isolates of Mycobacterium tuberculosis. Antimicrobial Agents and ChemoTherapy 48(11): 4447-4449, 2004

A comprehensive survey of single nucleotide polymorphisms (SNPs) across Mycobacterium bovis strains and M. bovis BCG vaccine strains refines the genealogy and defines a minimal set of SNPs that separate virulent M. bovis strains and M. bovis BCG strains. Infection and Immunity 77(5): 2230-2238, 2009

Detection and evaluation of the mutations of embB gene in ethambutol-susceptible and resistant Mycobacterium tuberculosis isolates from China. Chinese Medical Journal 118(20): 1739-1741, 2005

Transfer of embB codon 306 mutations into clinical Mycobacterium tuberculosis strains alters susceptibility to ethambutol, isoniazid, and rifampin. Antimicrobial Agents and ChemoTherapy 52(6): 2027-2034, 2008

EmbB gene mutations associated with ethambutol resistance in Indian strains of Mycobacterium tuberculosis. Current Science (Bangalore) 91(11): 1512-1517, 2006

Correlation of the phenotypic ethambutol susceptibility of Mycobacterium tuberculosis with embB gene mutations in Korea. Journal of Medical Microbiology 61(Pt 4): 529-534, 2012

Rapid detection of embB mutation in ethambutol-resistant Mycobacterium tuberculosis strains by using gene chip. Zhongguo Kangshengsu Zazhi 31(4): 225-228, 2006

Frequency of embB codon 306 mutations in ethambutol-susceptible and -resistant clinical Mycobacterium tuberculosis isolates in Kuwait. Tuberculosis 87(2): 123-129, 2007

Frequency of mutational changes in the embB among the ethambutol-resistant strains of Mycobacterium tuberculosis in Iran. Journal of Infection in Developing Countries 10(4): 363-368, 2017

Evolution of cell types and t cell subsets in the spleens of mycobacterium bovis bcg resistant and mycobacterium bovis bcg susceptible strains of mice after infection with mycobacterium bovis bcg. Infection & Immunity 49(1): 253-255, 1985

Correlation between ethambutol-resistance and embB gene mutation in Mycobacterium tuberculosis. Wei Sheng Yan Jiu 39(4): 506-508, 2012

Effect of ethambutol on the phospholipids of ethambutol susceptible and resistant strains of Mycobacterium smegmatis ATCC 607. Indian Journal of Biochemistry & Biophysics 27(1): 39-42, 1990

Rapid detection of ethambutol-resistant Mycobacterium tuberculosis strains by PCR-RFLP targeting embB codons 306 and 497 and iniA codon 501 mutations. Molecular and Cellular Probes 18(5): 299-306, 2004

Enhancement of drug susceptibility of multi-drug resistant strains of Mycobacterium tuberculosis by ethambutol and dimethyl sulphoxide. Journal of Antimicrobial ChemoTherapy 35(3): 381-390, 1995

A single point mutation in the embB gene is responsible for resistance to ethambutol in Mycobacterium smegmatis. Antimicrobial Agents and ChemoTherapy 41(12): 2629-2633, 1998